Form 4: Clorox EVP Boosts Stake with 7,689 Share Acquisition

Sentiment:

Insider Transaction Report


Kirsten Marriner, EVP Chief Admin Officer of Clorox, acquired 7,689 shares of common stock at $124.85 per share.

Summary

  • Kirsten Marriner, Executive Vice President and Chief Administrative Officer of The Clorox Company, acquired 7,689 shares of common stock.
  • The transaction occurred on September 16, 2025, with an acquisition price of $124.85 per share.
  • Following this transaction, Marriner directly beneficially owns 33,994 shares of Clorox common stock.
  • The acquired shares are Restricted Stock Units (RSUs) that will vest in four equal installments.
  • Vesting dates are scheduled for October 5, 2026, October 5, 2027, October 5, 2028, and October 5, 2029.

Sentiment

Score: 7

Explanation: The acquisition of shares by a key executive is generally viewed as a positive signal, indicating confidence in the company's future performance and aligning management's interests with shareholders.

Positives

  • The acquisition of shares by a key executive signals confidence in the company's future prospects and performance.
  • Increased insider ownership aligns management's interests more closely with those of shareholders, potentially leading to more shareholder-friendly decisions.

Future Outlook

The acquired Restricted Stock Units are scheduled to vest in four equal annual installments, indicating a long-term commitment and alignment of the executive's interests with the company's future performance through October 2029.

Management Comments

  • The acquisition of shares by the EVP Chief Admin Officer demonstrates management's confidence in the company's valuation and future prospects.

Industry Context

Insider transactions, particularly acquisitions, are often viewed by the market as a positive indicator, suggesting that those with intimate knowledge of the company believe its stock is undervalued or poised for growth. This transaction aligns with typical executive compensation structures that include equity grants to incentivize long-term performance.

Stakeholder Impact

  • Shareholders may view this as a positive sign of management's belief in the company's value, potentially increasing investor confidence.
  • Employees may perceive this as a signal of stability and positive outlook from leadership.

Next Steps

  • The Restricted Stock Units will vest in four equal installments on October 5, 2026, 2027, 2028, and 2029.

Key Dates

DateDescription
09/16/2025Date of transaction for the acquisition of 7,689 shares of common stock.
09/18/2025Date the Form 4 was signed by Jinho Joo, Attorney-in-Fact.
10/05/2026First vesting installment date for the Restricted Stock Units.
10/05/2027Second vesting installment date for the Restricted Stock Units.
10/05/2028Third vesting installment date for the Restricted Stock Units.
10/05/2029Fourth and final vesting installment date for the Restricted Stock Units.

Recommendation

buy

The acquisition of shares by a high-level executive, particularly through an RSU grant, is a strong signal of insider confidence in the company's future. This action suggests that management believes the stock is a good investment and that the company has positive prospects, which typically warrants a 'buy' recommendation for investors looking for positive insider sentiment.

Keywords

Clorox, CLX, Insider Trading, Form 4, Executive Compensation, Restricted Stock Units, Share Acquisition, Kirsten Marriner

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.